QA: Vincerx Pharma Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001796129_2024_Vincerx_Pharma_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001796129, Vincerx Pharma Inc

  xvar xval
0 AssetsCurrent 14,733,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 125,000
3 remainder_Assets 3,359,000
4 LiabilitiesCurrent 5,605,000
5 LiabilitiesNoncurrent 1,390,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,363,840
9 ResearchAndDevelopmentExpense 20,199,004
10 remainder_Expenses 2,410,096
11 remainder_Revenues 0
12 remainder_NetIncome 3,932,860
13 remainder_ComprehensiveNetIncome 61,116
  yvar yval
0 Assets 18,217,000
1 Liabilities 6,995,000
2 Expenses 35,972,940
3 Revenues 0
4 StockholdersEquity 11,222,000
5 NetIncome -32,040,080
6 ComprehensiveNetIncome -32,009,522
7 BaseVar 32,589,458
8 EconomicCapitalRatiobeforeLimitedLiability -0.599
9 EconomicCapitalRatio 1.37

Edgar->Model Mapping

Feature Distribution

Change over Time